Redox-dependent regulation of the expression of nitric oxide-inducible genes

Molecular Biology

Volumn 38, Issue 1, 2004, Pages 47-57

  Turpaev, K T ^a   Litvinov, D Yu ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Gene regulation; Nitric oxide; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

CYTOCHROME C OXIDASE; GUANYLATE CYCLASE; NITRIC OXIDE; PROTEIN TYROSINE KINASE; RAS PROTEIN; REACTIVE OXYGEN METABOLITE;

CYTOLOGY; GENE EXPRESSION; MOLECULE; OXIDATION REDUCTION REACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 3442882491     PISSN: 00268933     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MBIL.0000015139.68759.69     Document Type: Review

References (65)

1. Turpaev K.T. 2002. Reactive oxygen species and gene expression regulation. Biokhimiya. 67, 281-292.
2. Vanin A.F. 2001. Nitric oxide: Regulation of cell metabolism not involving the cell receptor system. Biofizika. 46, 631-641.
3. Thannickal V.J., Fanburg B.L. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1005-1028.
4. Marshall H.E., Merchant K., Stamler J.S. 2000. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 14, 1889-1900.
5. Nathan C., Xie Q. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell. 78, 915-918.
6. Groves J.T., Wang C.C. 2000. Nitric oxide synthase: models and mechanisms. Curr. Opin. Chem. Biol. 4, 687-695.
7. Elfering S.L., Sarkela T.M., Giulivi C. 2002. Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem. 277, 38079-38086.
8. Stamler J.S., Singel D.J., Loscalzo J. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science. 258, 1898-1892.
9. 2. Proc. Natl. Acad. Sci. USA. 98, 355-360.
10. Kirsch M., Korth H.G., Sustmann R., de Groot H. 2002. The pathobiochemistry of nitrogen dioxide. Biol. Chem. 383, 389-399.
11. Grisham M.B., Jourd'heuil D., Wink D.A. 1999. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276, G315-321.
12. 2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA. 195, 2175-2179.
13. Turpaev K., Litvinov D., Dubovaya V., Panasyuk A., Ivanov D., Prassolov V. 2001. Induction of vascular endothelial growth factor by nitric oxide in cultured human articular chondrocytes. Biochimie. 83, 515-522.
14. Turpaev K., Litvinov D., Justesen J. 2003. Redox modulation of NO-dependent induction of interleukin 8 in monocytic U937 cells. Cytokine. 23, 15-22.
15. Espey M.G., Miranda K.M., Thomas D.D., Wink D.A. 2001. Distinction between nitrosating mechanisms within human cells and aqueous solution. J. Biol. Chem. 276, 30085-30091.
16. Bogdan C. 2001. Nitric oxide and the regulation of gene expression. Trends Cell. Biol. 11, 66-75.
17. Wolin M.S. 2000. Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20, 1430-1442.
18. Schneiderhan N., Budde A., Zhang Y., Brune B. 2003. Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene. 22, 2857-2868.
19. Kim SJ., Hwang S.G., Shin D.Y., Kang S.S., Chun J.S. 2002. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF-κB-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 277, 33501-33508.
20. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., Luscher T.F. 2000. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation. 101, 1982-1989.
21. Severina I.S. 2002. Nitric oxide: The role of soluble guanylate cyclase in mechanisms of its physiological effects. Vopr. Med. Khim. 48, 4-30.
22. Stone J.R., Marletta M.A. 1996. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry. 35, 1093-1099.
23. Kalamkarov G.R., Ostrovskii M.A. 2002. Molekulyarnye mekhanizmy zritel'noi retseptsii (Molecular mechanisms of visual reception). Moscow: Nauka. 159-176.
24. Friebe A., Koesling D. 2003. Regulation of nitric oxide-sensitive guanylyl cyclase. Circ. Res. 93, 96-105.
25. Litvinov D.Yu., Dubovaya V.I., Vasil'ev M.G., Lekishvili M.V., Prasolov V.S., Turpaev K.T. 2003. The effect of catalase on the expression of NO-dependent genes in primary chondrocytes. Mol. Biol. 37, 482-485.
26. Zaragoza C., Soria E., Lopez E., Browning D., Balbin M., Lopez-Otin C., Lamas S. 2002. Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells. Mol. Pharmacol. 62, 927-935.
27. Wiggin G.R., Soloaga A., Foster J.M., Murray-Tait V., Cohen P., Arthur J.S. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22, 2871-2881.
28. Gudi T., Casteel D.E., Vinson C., Boss G.R., Pilz R.B. 2000. NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation. Oncogene. 19, 6324-6333.
29. Brown G.C., Borutaite V. 2002. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33, 1440-1450.
30. Sarkela T.M., Berthiaume J., Elfering S., Gybina A.A., Giulivi C. 2001. The modulation of oxygen radical production by nitric oxide in mitochondria. J. Biol. Chem. 276, 6945-6949.
31. Wink D.A., Kasprzak K.S., Maragos C.M, Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254, 1001-1003.
32. Xu W., Liu L.Z., Loizidou M., Ahmed M., Charles I.G. 2002. The role of nitric oxide in cancer. Cell Res. 12, 311-320.
33. Pleschke J.M., Kleczkowska H.E., Strohm M., Althaus F.R. 2000. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem. 275, 40974-40980.
34. Soum E., Brazzolotto X., Goussias C., Bouton C., Moulis J.M, Mattioli T.A., Drapier J.C. 2003. Peroxynitrite and nitric oxide differently target the iron-sulfur cluster and amino acid residues of human iron regulatory protein 1. Biochemistry. 42, 7648-7654.
35. Drapier J.C., Bouton C. 1996. Modulation by nitric oxide of metalloprotein regulatory activities. BioEssays. 18, 549-556.
36. Kim S., Ponka P. 2002. Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc. Natl. Acad. Sci. USA. 99, 12214-12219.
37. Ras S-nitrosylation and nitric oxide-mediated guanine nucleotide exchange. Proc. Natl. Acad. Sci. USA. 100, 6376-6381.
38. Wilkinson M.G., Millar J.B.A. 2000. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J. 14, 2147-2157.
39. Cohen P. 2000. The regulation of protein function by multisite phosphorylation - a 25 year update. Trends Biochem. Sci. 25, 596-601.
40. Herdegen, T., Leah, J.D. 1998. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28, 370-490.
41. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., Clark A.R. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21, 6461-6469.
42. Ming X.F., Stoecklin G., Lu M., Looser R., Moroni C. 2001. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol. Cell. Biol. 21, 5778-5789.
43. Dean J.L., Sarsfield S.J., Tsounakou E., Saklatvala J. 2003. p38 mitogen-activated protein kinase stabilises mRNAs that contain cyclooxygenase-2 and tumour necrosis factor AU-rich elements by inhibiting deadenylation. J. Biol. Chem. 278, 39470-39476.
44. Chumakov P.M. 2000. Functions of the p53 gene: A choice between life and death. Biokhimiya. 65, 34-47.
45. Dumaz N., Meek D.W. 1999. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002-7010.
46. Tatosyan A.G., Mizenina O.A. 2000. Kinases of the Src family: The structure and functions. Biokhimiya. 65, 57-67.
47. ε-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ. Res. 88, 1306-1313.
48. Dawn B., Bolli R. 2002. Role of nitric oxide in myocardial preconditioning. Ann. NY Acad. Sci. 962, 18-41.
49. Nakashima I., Kato M., Akhand A.A., Suzuki H., Takeda K., Hossain K., Kawamoto Y. 2002. Redox-linked signal transduction pathways for protein tyrosine kinase activation. Antioxid. Redox Signal. 4, 517-531.
50. Garbay C., Liu W.Q., Vidal M., Roques B.P. 2000. Inhibitors of Ras signal transduction as antitumor agents. Biochem. Pharmacol. 60, 1165-1169.
51. Perkins N.D. 2000. The Rel / NF-κB family: friend and foe. Trends Biochem. Sci. 25, 434-440.
52. Karin M., Lin A. 2002. NF-κB at the crossroads of life and death. Nature Immunol. 3, 221-227.
53. Janssen-Heininger Y.M., Poynter M.E., Baeuerle P.A. 2000. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Rad. Biol. Med. 28, 1317-1327.
54. Huang W.C., Chen J.J., Inoue H., Chen C.C. 2003. Tyrosine phosphorylation of IκB kinase α/β by protein kinase C-dependent c-Src activation is involved in TNFα-induced cyclooxygenase-2 expression. J. Immunol. 170, 4767-4775.
55. Malyshev I.Yu., Monastyrskaya E.A., Smirin B.V., Manukhina E.B. 2000. Hypoxia and nitric oxide. Vestn. Ross. Akad. Med. Nauk. No. 9, 44-48
56. Dulak J., Jozkowicz A. 2003. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid. Redox. Signal. 5, 123-132.
57. Semenza G. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64, 993-998.
58. D'Angelo G., Duplan E., Boyer N., Vigne P., Frelin C. 2003. Hypoxia up regulates prolyl hydroxylase. A feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278, 38183-38187.
59. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. 2002. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
60. Sandau K.B., Zhou J., Kietzmann T., Brune B. 2001. Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805-39811.
61. Metzen E., Zhou J., Jelkmann W., Fandrey J., Brune B. 2003. Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol. Biol. Cell. 14, 3470-3481.
62. Sumbayev V.V., Budde A., Zhou J., Brune B. 2003. HIF-1α protein as a target for S-nitrosation. FEBS Lett. 535, 106-112.
63. Piantadosi C.A., Tatro L., Zhang J. 1995. Hydroxyl radical production in the brain after CO hypoxia in rats. Free Radic. Biol. Med. 18, 603-609.
64. Mazure N.M., Brahimi-Horn M.C., Pouyssegur J. 2003. Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis. Curr. Pharm. 9, 531-541.
65. Yasinska I.M., Sumbayev V.V. 2003. S-nitrosation of Cys-800 of HIF-1α protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 549, 105-109.